HKU Scholars Hub: Browsing DSpace

Browsing by Subject tyrosine kinase inhibitor

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 11 of 11

	Title	Author(s)	Issue Date
	A phase II study of sorafenib in malignant mesothelioma: Results of Cancer and Leukemia Group B 30307 Journal:Journal of Thoracic Oncology	Dubey, S Jänne, PA Krug, L Pang, H Wang, X Heinze, R Watt, C Crawford, J Kratzke, R Vokes, E Kindler, HL	2010
	Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Research and Treatment	Dai, MS Feng, YH Chen, SW Masuda, N Yau, T Chen, ST Lu, YS Yap, YS Ang, PCS Chu, SC Kwong, A Lee, KS Ow, S Kim, SB Lin, J Chung, HC Ngan, R Kok, VC Rau, KM Sangai, T Ng, TY Tseng, LM Bryce, R Bebchuk, J Chen, MC Hou, MF	2021
	Control of brain metastases with alectinib in anaplastic lymphoma kinase-rearranged lung cancer Journal:Respirology Case Reports	Kwok, WC Tam, CCT Lui, MSM Lam, CLD Ho, JCM	2017
	EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib Journal:BMC Bioinformatics	Ma, L Wang, DD Huang, Y Yan, H Wong, MP Lee, VHF	2015
	ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis Journal:Cancer Letters	Tan, H-Y Wang, N Chan, Y-T ZHANG, C GUO, W CHEN, F Zhong, Z Li, S Feng, Y	2020
	Local and systemic treatment for HER2-positive breast cancer with brain metastases: a comprehensive review Journal:Therapeutic Advances in Medical Oncology	Chan, WL Lam, TC Lam, KO Luk, MY Ngan, RKC Kwong, D	2020
	Personalized Treatment of Lung Adenocarcinoma Journal:Clinical Pulmonary Medicine	Ho, JCM Tam, CCT Lam, SK	2013
	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Journal:Investigational New Drugs	Bang, Yung Jue Kang, Yoon Koo Kang, Won K.Boku, Narikazu Chung, Hyun C.Chen, Jen Shi Doi, Toshihiko Sun, Yan Shen, Lin Qin, Shukui Ng, Wai Tong Tursi, Jennifer M.Lechuga, Maria J.Lu, Dongrui Ray Ruiz-Garcia, Ana Sobrero, Alberto	2011
	Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial Journal:ESMO Open	Kelley, RK Ryoo, BY Merle, P Park, JW Bolondi, L Chan, SL Lim, HY Baron, AD Parnis, F Knox, J Cattan, S Yau, T Lougheed, JC Milwee, S El-Khoueiry, AB Cheng, AL Meyer, T Abou-Alfa, GK	2020
	Severe bradycardia associated with crizotinib Journal:Postgraduate Medical Journal	Ko, KL Liu, C Cheung, BMY	2017
	TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical Resection Journal:Clinical Lung Cancer	Soo, Ross Andrew de Marinis, Filippo Han, Ji Youn Ho, James Chung Man Martin, Emma Servidio, Leslie Sandelin, Martin Popat, Sanjay	3-Oct-2023

Showing results 1 to 11 of 11